Although the survival analysis uncovered both high and low expression levels of GLS2 in certain types of cancer, including bladder and lung cancer, the Oncomine databased was unable to provide such expression patterns (Figure 1a), unlike for GLS. The gene discussed is GLS2; the disease is lung cancer.